Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting 5α-reductase during late pregnancy shortens gestation, reduces litter size, and harms memory in rat offspring.

Naltrexone shows promise as a safe treatment for a type of hair loss called lichen planopilaris.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Long-term treatment with buprenorphine/naloxone for opioid addiction may lead to secondary adrenal insufficiency.

Niacin derivatives may increase hair fullness in women with hair loss.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Finasteride doesn't affect hormone levels in normal men.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Finasteride slows down motherly behavior in first-time pregnant rats.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Finasteride safely lowers DHT levels without affecting testosterone.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Etretinate treatment changed hair growth patterns in many patients.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

17β-Estradiol boosts allergic reactions and slows thymus aging in mice.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Monitoring for adverse effects in clinical treatments is crucial.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.